American Generics (India) Limited
Manufactures generic formulations and pharmaceutical raw materials for US partner.
1995 | Hyderabad, Telangana (India) | Active
American Generics (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 2.68 M
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6.18%
- Profit Growth -111.45%
- Ebitda -1347.44%
- Net Worth -1.73%
- Total Assets 4.90%
About American Generics (India)
American Generics (India) Limited (AGIL) is a Public Limited Indian Non-Government Company incorporated in India on 19 April 1995 and has a history of 29 years and 11 months. Its registered office is in Hyderabad, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.68 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Srivastava, Bhupendera Ramakrishnan, Lalitha Ramakrishnan, and One other member serve as directors at the Company.
Company Details
- Location Hyderabad, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG1995PLC020046
- Company No.
020046
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
American Generics (India) Limited
Explore comprehensive data for American Generics (India) Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at American Generics (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatasubrahmanyan Ramakrishnan  | Managing Director | 19-Apr-1995 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhupendera Ramakrishnan | Director | 28-May-2018 | Current |
| Sunil Srivastava | Director | 19-Apr-1995 | Current |
| Lalitha Ramakrishnan | Director | 04-Jul-2001 | Current |
Financial Performance of American Generics (India).
American Generics (India) Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial fall in profitability, with a 111.45% decrease in profit. The company's net worth dipped by a decrease of 1.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of American Generics (India)?
In 2018, American Generics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balaji Rail Road Systems Private LimitedSunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
- Lipicard Technologies Limited
Sunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
- Integrated Rail Services Private Limited
Sunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at American Generics (India)?
Unlock and access historical data on people associated with American Generics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of American Generics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Generics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on American Generics (India)
Recent activity within the organization
- Annual General Meeting
American Generics (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
American Generics (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Bhupendera Prashanth Ramakrishnan was appointed as a Director was appointed as a Director on 28 May 2018 & has been associated with this company since 6 years 10 months .
- Director Appointment
Lalitha Ramakrishnan was appointed as a Director was appointed as a Director on 04 Jul 2001 & has been associated with this company since 23 years 9 months .
- Director Appointment
Sunil Srivastava was appointed as a Director was appointed as a Director on 19 Apr 1995 & has been associated with this company since 29 years 11 months .
- Director Appointment
Venkatasubrahmanyan Ramakrishnan was appointed as a Managing Director was appointed as a Managing Director on 19 Apr 1995 & has been associated with this company since 29 years 11 months .
Frequently asked questions
What is the Incorporation or founding date of American Generics (India) Limited?
American Generics (India) Limited was incorporated on 19 Apr 1995.
What is authorized share capital and paid-up capital of American Generics (India) Limited?
The authorized share capital of American Generics (India) Limited is ₹ 1.00 Cr and paid-up capital is ₹ 2.68 M.
Who are the current board members & directors of American Generics (India) Limited?
Currently 4 directors are associated with American Generics (India) Limited.
- Sunil Srivastava
- Bhupendera Prashanth Ramakrishnan
- Lalitha Ramakrishnan
- Venkatasubrahmanyan Ramakrishnan
What is the registered address of American Generics (India) Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of American Generics (India) Limited is Flat No.301 Sri Rama Mountview Road No.2 Banjarahills, India, Hyderabad, Telangana.
What is the corporate identification number (CIN) and company number of American Generics (India) Limited?
The corporate identification number (CIN) of American Generics (India) Limited is U24239TG1995PLC020046 and the company number is 020046 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for American Generics (India) Limited?
According to the financial reports for the fiscal year 2019, the revenue trend for American Generics (India) Limited has risen by 6.18%.
What change has been observed in the net worth of American Generics (India) Limited, and by what percentage?
The financial reports for the fiscal year 2019 indicates that The net worth of American Generics (India) Limited has experienced an downturn of -1.73%.
When was the last Balance Sheet of American Generics (India) Limited filed with the ROC?
The most recent Balance Sheet for American Generics (India) Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records